Company news
Oncology Pharma Inc. news in 2020
Oncology Pharma Inc.'s news releases, calls and decks from 2020, newest first.
Oncology Pharma Announces Extension of Letter of Intent with Kalos Therapeutics, Retained an Interim CEO and Approval of Reverse Stock Split
August 27, 2020
Oncology Pharma Licensor and Co-Development Partner, Kalos Therapeutics, Announces Progress in Covid-19 Preventative & Therapeutic Approaches
April 20, 2020
Oncology Pharma and Kalos Therapeutics Expand Licensing Agreement for Exploring Kalos's Anti-Cancer Lead Drug in Treating COVID-19
April 6, 2020
Oncology Pharma, Inc. Narrows Focus on Funding Efforts
January 28, 2020